Background Angiosarcomas are a rare but aggressive form of soft tissue sarcoma. At
metastatic stage, the clinical benefit of therapeutic intervention remains debatable. Patients …

Background: Angiosarcomas (AS) are rare tumors of vascular origin with a variable behavior
and overall poor prognosis. We sought to assess the outcomes of patients treated for …

Objective: Angiosarcoma is an aggressive malignancy with endothelial differentiation and
notoriously poor prognosis despite aggressive therapy. Limited data are available to guide …

BACKGROUND: Data regarding the role of anthracyclines and taxanes as first‐line
treatments of metastatic angiosarcoma are limited. METHODS: Records of 117 metastatic …

Background Angiosarcomas are rare, heterogeneous and a retrospective study was
conducted to describe their natural history. Patients and methods We reviewed 161 files of …

Background Angiosarcoma (AS) is a rare soft tissue sarcoma with an enhanced propensity
for local and systemic failure. The outcome of locally recurrent and metastatic AS treated at a …

We propose a literature review of available data on angiosarcoma (AS). AS account for 1%
of adult soft tissue sarcoma. Two risk factors are well-establish chronic lymhoedema …

Background Angiosarcomas are an uncommon type of malignancy that are generally
thought to behave usually in a locally aggressive fashion; they often metastasize to distant …

PURPOSE Angiosarcoma is a rare vascular malignancy, and there are few published data
to guide chemotherapy treatment decisions. We present a retrospective analysis of …

Angiosarcoma represents 1 to 2% of soft tissue tumors. It originates from endothelial cells of
small blood vessels and may affect a variety of organs, including the retroperitoneum …